E. Picano et al., PROGNOSTIC VALUE OF DIPYRIDAMOLE-ECHOCARDIOGRAPHY EARLY AFTER UNCOMPLICATED MYOCARDIAL-INFARCTION - A LARGE-SCALE, MULTICENTER TRIAL, The American journal of medicine, 95(6), 1993, pp. 608-618
PURPOSE: To determine the prognostic capability of the dipyridamole ec
hocardiography test (DET) early after an acute myocardial infarction.
PATIENTS AND METHODS: On the basis of 11 different echocardiographic l
aboratories, all with established experience in stress echocardiograph
y and fulfilling quality-control requirements for stress echocardiogra
phic readings, 925 patients were evaluated after a mean of 10 days fro
m an acute myocardial infarction and followed up for a mean of 14 mont
hs. RESULTS: During the follow-up, there were 34 deaths and 37 nonfata
l myocardial infarctions; 104 patients developed class III or IV angin
a and 149 had coronary revascularization procedures (bypass or angiopl
asty). Considering all spontaneous events (angina, reinfarction, and d
eath), the most important univariate predictor was the presence of an
inducible wall motion abnormality after dipyridamole administration (c
hi2 = 45.8). With a Cox analysis, echocardiographic positivity, age, a
nd male gender were found to have an independent and additive value. C
onsidering survival (and, therefore, death as the only event), age was
the most meaningful parameter, followed by the wall motion score inde
x during dipyridamole administration (chi2 = 12.1). Among other parame
ters, the resting wall motion score index was a significant predictor
of death. In a multivariate analysis, the prognostic contributions of
age (relative risk estimate = 1.08) and wall motion score index during
dipyridamole administration (relative risk estimate = 4.1) were indep
endent and additive. In particular, considering death only, the event
rate was 2% in patients with negative DET results, 4% in patients with
positive high-dose DET results, and 7% in patients with positive low-
dose DET results. CONCLUSIONS: DET is feasible and safe early after un
complicated myocardial infarction and allows effective risk stratifica
tion on the basis of the presence, severity, extent, and timing of the
induced dyssynergy.